Device Ent

Acclarent Aera

Payments companies reported to CMS as associated with Acclarent Aera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$636Kassociated payments (2023-2025)

3,375clinicians with associated payments

5companies reporting

By year

2023 $49K

2024 $375K

2025 $212K

Payments reported as associated with Acclarent Aera, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Otolaryngology $410K

Otolaryngology/Facial Plastic Surgery $50K

Pediatric Otolaryngology $38K

Otology & Neurotology $29K

Physician Assistant $13K

Facial Plastic Surgery $11K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Acclarent Aera

These are the largest totals companies reported as associated with Acclarent Aera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Prasad Thottam	West Bloomfield, MI	Otolaryngology/Facial Plastic Surgery	$21,707.12
Yi-Chun Liu	Houston, TX	Pediatric Otolaryngology	$16,507.44
Shraddha Mukerji	Galveston, TX	Otolaryngology	$14,673.34
Seilesh Babu	Farmington Hills, MI	Otology & Neurotology	$14,277.87
Douglas Reh	Lutherville Timonium, MD	Otolaryngology	$14,223.79
Daniel Charous	Goodyear, AZ	Otolaryngology	$14,052.67
David Fortune	Hermitage, TN	Otolaryngology	$13,698.06
Raymond Weiss	Ocean Springs, MS		$13,352.18
Nadeem Akbar	Tampa, FL	Otolaryngology	$10,916.02
Kyra Osborne	Cleveland, OH	Otolaryngology	$10,559.30

Prescribed Acclarent Aera?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.